Metabolism of praziquantel in kingfish Seriola lalandi

Stereoselective Pharmacokinetics and Residue Depletion of Praziquantel and Its Metabolites, 4-Hydroxypraziquantel Enantiomers, in Swine

Praziquantel (PZQ) is administered as a racemic mixture during swine production to treat parasitic diseases. Despite its widespread application, the pharmacokinetics, residue depletion, bioactivity, and toxicity of PZQ enantiomers in swine remain largely unknown. In this study, a systematic investigation of the pharmacokinetics, tissue distribution, and residue depletion of PZQ, its major metabolites (trans- and cis-4-OH-PZQ), and their enantiomers was conducted in swine. The findings indicated that PZQ was absorbed and metabolized rapidly. In swine plasma, the concentrations of S-PZQ, S-trans-4-OH-PZQ, and R-cis-4-OH-PZQ were higher than those of their respective enantiomers. The three analytes exhibited significant tissue distribution and stereoselectivity in 10 swine tissues. Notably, the two enantiomers of PZQ demonstrated comparable tissue concentrations except in the liver and lung. Moreover, the concentrations of S-trans-4-OH-PZQ and R-cis-4-OH-PZQ were higher than those of their respective enantiomers in the 10 tissues. This study has significant implications for the development of rational dosing strategies, reducing drug usage, and minimizing side effects, as well as accurately assessing the risks associated with PZQ administration and, by extension, other chiral drugs. Furthermore, it lays a theoretical foundation for the future use of the active enantiomer, R-PZQ.

Preliminary Monitoring of Praziquantel in Water and Sediments at a Japanese Amberjack (Seriola quinqueradiata) Aquaculture Site

Praziquantel (PZQ), an active compound against Platyhelminthes, is an essential anthelmintic for the aquaculture industry. However, there are few reports of the environmental risks of PZQ use in aquaculture. In this study, we monitored PZQ in water and sediment at an aquaculture site of Japanese amberjack, also called yellowtail (Seriola quinqueradiata). Although PZQ was detected in water during treatment and 3 days post-treatment, PZQ levels were below the detectable limit in water 60 m from the net pen during the treatment, and in all sediment samples. In this preliminary study, we could not detect residue of PZQ from sediments in the aquaculture site, and no evidence about environmental effect of PZQ administration was obtained.

Use of praziquantel to control platyhelminth parasites of fish

Fish are common definitive and intermediate hosts for a variety of parasitic flatworms. In unstressed wild populations, parasitic infections often go unnoticed and are perceived to represent a lesser threat to fish health. In contrast, platyhelminth parasitism of captive fish often results in decreased weight gain and increased mortality which often necessitates chemotherapeutic treatment. The presence of platyhelminth parasites in fish tissues is not only unappealing but in some cases also represents a threat to human health. In veterinary medicine, one of the most commonly used agents with anti-flatworm activity is praziquantel; yet, no praziquantel products are labeled for use in fish in the United States. Veterinarians may use praziquantel preparations approved for other vertebrate species under the Animal Medicinal Drug Use Clarification Act (AMDUCA). However, such extra-label use should be informed by scientific evidence including efficacy and tissue residue studies. Herein, we review studies testing the efficacy of praziquantel for treatment of platyhelminthes along with an assessment of routes of administration, pharmacokinetics, and toxicity information.

Study of praziquantel phytoremediation and transformation and its removal in constructed wetland

Accumulation and/or degradation of Praziquantel (PZQ) in plants were determined using Phragmites australis, both suspension cultures and in vitro cultivated plants. In case of initial PZQ concentration 20mgL^-1, 90% was removed from liquid media within 21days. The accumulated PZQ was partly metabolized, twenty one compounds being identified, products of both Phase I and II of detoxification metabolism. Laboratory results were confirmed in real scale using the constructed wetland (CW), where PZQ (500mg in total) was completely removed until the first purification pond. This result offers a promising possibility to use CW for PZQ removal from agricultural as well as domestic waste-waters.

Pharmacokinetics and residue depletion of praziquantel in rice field eels Monopterus albus

We investigated the pharmacokinetic characteristics of praziquantel (PZQ) in rice field eels Monopterus albus. Pharmacokinetic parameters were determined following a single intravenous administration (5 mg kg(-1) body weight [bw]) and a single oral administration (10 mg kg(-1) bw) at 22.0 ± 0.7°C. We also evaluated residue depletion in tissues following daily administration of PZQ (10 mg kg(-1) bw) that was given orally for 3 consecutive days at 22.0 ± 0.7°C. Following intravenous treatment, the plasma concentration-time curve was best described by a 3-compartment open model, with distribution half-life (t(1/2α)), elimination half-life (t(1/2β)), and area under the concentration-time curve (AUC) of 0.54 h, 17.10 h, and 14505.12 h µg l(-1), respectively. After oral administration, the plasma concentration-time curve was best described by a 1-compartment open model with first-order absorption, with absorption half-life (t(1/2Ka)), elimination half-life (t(1/2Ke)), peak concentration (C(max)), time-to-peak concentration (T(max)), and AUC estimated to be 2.28 h, 6.66 h, 361.29 µg l(-1), 5.36 h, and 6065.46 h µg l(-1), respectively. The oral bioavailability (F) was 20.9%. With respect to residue depletion of PZQ, the t(1/2β) values of muscle, skin, liver, and kidney were 20.2, 28.4, 14.9, and 54.1 h, respectively. Our results indicated rapid absorption, rapid elimination, and low bioavailability of PZQ in rice field eels at the tested dosing conditions.

Praziquantel degradation in marine aquarium water

Praziquantel (PZQ) is a drug commonly utilized to treat both human schistosomiasis and some parasitic infections and infestations in animals. In the aquarium industry, PZQ can be administered in a "bath" to treat the presence of ectoparasites on both the gills and skin of fish and elasmobranchs. In order to fully treat an infestation, the bath treatment has to maintain therapeutic levels of PZQ over a period of days or weeks. It has long been assumed that, once administered, PZQ is stable in a marine environment throughout the treatment interval and must be mechanically removed, but no controlled experiments have been conducted to validate that claim. This study aimed to determine if PZQ would break down naturally within a marine aquarium below its 2 ppm therapeutic level during a typical 30-day treatment: and if so, does the presence of fish or the elimination of all living biological material impact the degradation of PZQ? Three 650 L marine aquarium systems, each containing 12 fish (French grunts: Haemulon flavolineatum), and three 650 L marine aquariums each containing no fish were treated with PZQ (2 ppm) and concentrations were measured daily for 30 days. After one round of treatment, the PZQ was no longer detectable in any system after 8 (±1) days. The subsequent two PZQ treatments yielded even faster PZQ breakdown (non-detectable after 2 days and 2 ± 1 day, respectively) with slight variations between systems. Linear mixed effects models of the data indicate that day and trial most impact PZQ degradation, while the presence of fish was not a factor in the best-fit models. In a completely sterilized marine system (0.5 L) PZQ concentration remained unchanged over 15 days, suggesting that PZQ may be stable in a marine system during this time period. The degradation observed in non-sterile marine systems in this study may be microbial in nature. This work should be taken into consideration when providing PZQ bath treatments to marine animals to ensure maximum drug administration.

Praziquantel treatment for yellowtail kingfish (Seriola lalandi): dose and duration safety study

Regulatory approval is being sought to use praziquantel (PZQ) to treat flukes infecting yellowtail kingfish (YTK), but accurate safety data were not available. We investigated the effect of increased doses or prolonged exposure of orally administered PZQ on YTK by assessing changes in haematological and biochemical characteristics, and mortality. Fish were intubated daily for 3 days with 0, 100, 300 and 500 mg PZQ kg(-1) BW day(-1) or once daily for 9 days at 0 and 100 mg PZQ kg(-1) BW day(-1). Blood was taken 24 h after the cessation of treatment. There was no significant difference between any of the haematological or biochemical indices in YTK treated with PZQ and controls, indicating that PZQ is safe for use at 100 mg PZQ kg(-1) BW day(-1) in YTK and that exposure to high doses or prolonged duration does not have negative effects on the YTK haematological or biochemical parameters we measured.

Australian farmed Yellowtail Kingfish (Seriola lalandi) and Mulloway (Argyrosomus hololepidotus): residues of metallic, agricultural and veterinary chemicals, dioxins and polychlorinated biphenyls

Composite samples of Australian farmed Yellowtail Kingfish (Seriola lalandi) (YTKF) (n=27), Mulloway (Argyrosomus hololepidotus) (n=6) and manufactured feed (n=5) were analysed to benchmark levels of a broad range of residues and contaminants of potential public health and trade significance. A subset of these samples [YTKF (n=5), Mulloway (n=2) and feed (n=5)] was analysed for dioxins and polychlorinated biphenyls (PCBs). The mean concentration of dioxins in YTKF was 0.6 pg TEQ g(-1) (range 0.22-0.8) and in Mulloway was 0.16 pg TEQ g(-1) (range 0.16-0.16). The mean concentration of dioxins and dioxin-like PCBs in YTKF was 2.6 pg TEQ g(-1) (range 1.4-3.5), while Mulloway had a mean concentration of 0.67 pg TEQ g(-1) (range 0.57-0.76). The mean concentration of PCBs in YTKF was 21 μg kg(-1) (range 8.6-29) and in Mulloway was 5.4 μg kg(-1) (mean 4.7-6). The mean concentration of dioxin-like PCBs in YTKF was 2.1 pg TEQ g(-1) (range 1.2-2.8) and in Mulloway was 0.51 pg TEQ g(-1) (range 0.41-0.61). The mean mercury concentration in YTKF was 0.03 mg kg(-1) (range 0.02-0.05) and in Mulloway it was 0.02 mg kg(-1) (range 0.02-0.04). There were no detectable levels of any pesticide or antimicrobial compounds in any sample of YTKF or Mulloway. Attention is drawn to technical differences in port of entry testing programs such as sampling strategies, portion tested, laboratory methodology, residue definitions and reporting conventions that exporters' products may be subject to. All residues and contaminants were either undetectable or present at very low levels when judged against Australian, Japanese and European Union regulatory standards (where set).